Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
5-Amino-1MQ is not approved by the FDA, EMA, or any other regulatory authority for any indication
AOD-9604 has substantial Phase 1, 2, and IIb research from Metabolic Pharmaceuticals' development program
One individual per group was euthanized before addressing the next animal in each group to render differences arising from the time of day at euthanization (e.g., cecal mass changes resulting from differences in time post-food consumption) comparable across all groups
By blocking NNMT, it helps increase NAD+ levels, which in turn supports metabolic health and fat oxidation
US$ 22.21
US$ 29.63
US$ 24.36
